Skip to content

Impulse™ H749163911001Recalls & reported problems

Boston Scientific Corporation · Angiographic Catheter · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729344070), received between Aug 18, 2022 and Aug 18, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Difficult to Advance” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Difficult to Advance1

Patient problems

  • Brain Injury1
  • Muscle Weakness/Atrophy1
  • Stroke/CVA1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 18, 2022Difficult to Advance; Difficult to Advance

    IT WAS REPORTED THAT AN EMBOLIC STROKE OCCURRED RESULTING IN EXPRESSIVE APHASIA. ON (B)(6) 2022, AN IMPLUSE DIAGNOSTIC GUIDE CATHETER WAS SELECTED FOR USE IN A CORONARY INTERVENTION PROCEDURE. THE IMPLUSE TOOK 4 MINS TO CROSS THE VALVE. POST PROCEDURE, WITHIN THE SAME MONTH AS THE INITIAL PROCEDURE, THE PATIENT EXPERIENCED AN EMBOLIC STROKE REQUIRING HOSPITAL TREATMENT. THE PATIENT EXPERIENCED MEMORY LOSS AND LEFT SIDE WEAKNESS POST STROKE. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Brain Injury; Muscle Weakness/Atrophy; Stroke/CVA

    MAUDE report 15255055 ↗

Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices

All CATHETER, INTRAVASCULAR, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page